Introduction: On-label and off-label drug use in reproductive medicine

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This Views and Reviews article examines FDA-approved uses of prescription drugs, as well as common off-label uses of drugs for several disorders that are frequently seen in reproductive medicine. Off-label drug use is ubiquitous in reproductive medicine, a fact that may be related to the disincentives to formally study these drugs in a potentially vulnerable population (i.e., pregnant women). It behooves clinicians to discuss with patients the risk-benefit ratio of treatment, and whether a treatment is FDA-approved for that condition. Researchers, seeking better data on effects of these drugs, may find fodder for future clinical studies in these articles.

Original languageEnglish (US)
Pages (from-to)581-582
Number of pages2
JournalFertility and Sterility
Volume103
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Off-Label Use
Reproductive Medicine
Pharmaceutical Preparations
Prescription Drugs
Vulnerable Populations
Motivation
Pregnant Women
Odds Ratio
Research Personnel
Therapeutics

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

@article{81f7daeb06714ad7a02fe748aaea8aac,
title = "Introduction: On-label and off-label drug use in reproductive medicine",
abstract = "This Views and Reviews article examines FDA-approved uses of prescription drugs, as well as common off-label uses of drugs for several disorders that are frequently seen in reproductive medicine. Off-label drug use is ubiquitous in reproductive medicine, a fact that may be related to the disincentives to formally study these drugs in a potentially vulnerable population (i.e., pregnant women). It behooves clinicians to discuss with patients the risk-benefit ratio of treatment, and whether a treatment is FDA-approved for that condition. Researchers, seeking better data on effects of these drugs, may find fodder for future clinical studies in these articles.",
author = "Richard Legro",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.fertnstert.2015.01.028",
language = "English (US)",
volume = "103",
pages = "581--582",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "3",

}

Introduction : On-label and off-label drug use in reproductive medicine. / Legro, Richard.

In: Fertility and Sterility, Vol. 103, No. 3, 01.03.2015, p. 581-582.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Introduction

T2 - On-label and off-label drug use in reproductive medicine

AU - Legro, Richard

PY - 2015/3/1

Y1 - 2015/3/1

N2 - This Views and Reviews article examines FDA-approved uses of prescription drugs, as well as common off-label uses of drugs for several disorders that are frequently seen in reproductive medicine. Off-label drug use is ubiquitous in reproductive medicine, a fact that may be related to the disincentives to formally study these drugs in a potentially vulnerable population (i.e., pregnant women). It behooves clinicians to discuss with patients the risk-benefit ratio of treatment, and whether a treatment is FDA-approved for that condition. Researchers, seeking better data on effects of these drugs, may find fodder for future clinical studies in these articles.

AB - This Views and Reviews article examines FDA-approved uses of prescription drugs, as well as common off-label uses of drugs for several disorders that are frequently seen in reproductive medicine. Off-label drug use is ubiquitous in reproductive medicine, a fact that may be related to the disincentives to formally study these drugs in a potentially vulnerable population (i.e., pregnant women). It behooves clinicians to discuss with patients the risk-benefit ratio of treatment, and whether a treatment is FDA-approved for that condition. Researchers, seeking better data on effects of these drugs, may find fodder for future clinical studies in these articles.

UR - http://www.scopus.com/inward/record.url?scp=84926064059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926064059&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2015.01.028

DO - 10.1016/j.fertnstert.2015.01.028

M3 - Article

C2 - 25726701

AN - SCOPUS:84926064059

VL - 103

SP - 581

EP - 582

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 3

ER -